These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 34935899)

  • 21. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway.
    Zhu MJ; Xie S; Xie Q; Zhu JL; Huang YZ
    J Tradit Chin Med; 2021 Dec; 41(6):853-861. PubMed ID: 34939381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
    Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
    Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-resistant exosome miR-99b-3p induces macrophage polarization and confers chemoresistance on sensitive cells by targeting PPP2CA.
    Mao H; Ye R; Tang G; Tao S; Wei K; Wu Y; Pang S; Wang J; Shi J; Ji Y; Xiao Y; Geng C; Wang W; Chen C; Yang Q
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113168. PubMed ID: 39298813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells.
    Hakeem AN; El-Kersh DM; Hammam O; Elhosseiny A; Zaki A; Kamel K; Yasser L; Barsom M; Ahmed M; Gamal M; Attia YM
    Sci Rep; 2024 Aug; 14(1):18181. PubMed ID: 39107323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosome-Derived MicroRNA-221-3p Desensitizes Breast Cancer Cells to Adriamycin by Regulating
    Hong X; Pan X
    Cancer Biother Radiopharm; 2024 Aug; 39(6):463-475. PubMed ID: 38529940
    [No Abstract]   [Full Text] [Related]  

  • 28. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.
    Wu HT; Lin J; Liu YE; Chen HF; Hsu KW; Lin SH; Peng KY; Lin KJ; Hsieh CC; Chen DR
    Phytomedicine; 2021 Jan; 81():153437. PubMed ID: 33352494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hijacking 5-Fluorouracil Chemoresistance in Triple Negative Breast Cancer via microRNAs-Loaded Chitosan Nanoparticles.
    Fahmy SA; Mahdy NK; Mohamed AH; Mokhtar FA; Youness RA
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.
    Gohr K; Hamacher A; Engelke LH; Kassack MU
    BMC Cancer; 2017 Nov; 17(1):711. PubMed ID: 29100507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-1205/DNAJB1 reverses docetaxel chemoresistance in human triple negative breast carcinoma cells via regulation of mutp53/TAp63 signaling.
    Yin Y; Zhang J; Ma T; Chen D; Lu D
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(1):37-46. PubMed ID: 35130632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircEGFR reduces the sensitivity of pirarubicin and regulates the malignant progression of triple-negative breast cancer via the miR-1299/EGFR axis.
    Ma J; Chen C; Fan Z; Zhang Y; Ji J; Wei D; Zhang F; Sun B; Huang P; Ren L
    Int J Biol Macromol; 2023 Jul; 244():125295. PubMed ID: 37302631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 34. Chamomile Essential Oil: Chemical Constituents and Antitumor Activity in MDA-MB-231 Cells through PI3K/Akt/mTOR Signaling Pathway.
    An Z; Feng X; Sun M; Wang Y; Wang H; Gong Y
    Chem Biodivers; 2023 Apr; 20(4):e202200523. PubMed ID: 36941224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PI3K/mTOR dual inhibitor NVP-BEZ235 stimulates mutant p53 degradation to exert anti-tumor effects on triple-negative breast cancer cells.
    Cai J; Xia J; Zou J; Wang Q; Ma Q; Sun R; Liao H; Xu L; Wang D; Guo X
    FEBS Open Bio; 2020 Apr; 10(4):535-545. PubMed ID: 32027103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ST8SIA1 inhibition sensitizes triple negative breast cancer to chemotherapy via suppressing Wnt/β-catenin and FAK/Akt/mTOR.
    Wan H; Li Z; Wang H; Cai F; Wang L
    Clin Transl Oncol; 2021 Apr; 23(4):902-910. PubMed ID: 32939659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA GHET1 Promotes the Progression of Triple-Negative Breast Cancer
    Wang Y; Li C
    Comput Math Methods Med; 2022; 2022():8366569. PubMed ID: 35509860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
    Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
    Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.
    Zhao M; Zhang M; Tao Z; Cao J; Wang L; Hu X
    Technol Cancer Res Treat; 2020; 19():1533033820905824. PubMed ID: 32174262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells.
    Fu R; Tong JS
    J Cell Mol Med; 2020 Jul; 24(13):7600-7608. PubMed ID: 32410348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.